Goldman Sachs’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $32.6K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $550K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $39K | Sell |
|
|||||
|
2023
Q2 | $399K | Sell |
|
|||||
|
2023
Q1 | $452K | Sell |
|
|||||
|
2022
Q4 | $913K | Buy |
|
|||||
|
2022
Q3 | $2.64M | Sell |
|
|||||
|
2022
Q2 | $3.5M | Buy |
|
|||||
|
2022
Q1 | $791K | Sell |
|
|||||
|
2021
Q4 | $1.9M | Sell |
|
|||||
|
2021
Q3 | $2.26M | Buy |
|
|||||
|
2021
Q2 | $238K | Sell |
|
|||||
|
2021
Q1 | $376K | Sell |
|
|||||
|
2020
Q4 | $452K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $3.62M | Buy |
|
|||||
|
2019
Q4 | $211K | Buy |
|